메뉴 건너뛰기




Volumn 15, Issue 1, 2016, Pages

Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats

Author keywords

Free fatty acids; Lipid metabolism; Non alcoholic fatty liver disease; Oxidative stress; Triglycerides

Indexed keywords

ACIPIMOX; ALANINE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A; CARNITINE PALMITOYLTRANSFERASE I; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; MALONALDEHYDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 84957704285     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-016-0194-7     Document Type: Article
Times cited : (105)

References (26)
  • 1
    • 77952576769 scopus 로고    scopus 로고
    • Epidemiology of non-alcoholic fatty liver disease
    • 20460905
    • Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28:155-61.
    • (2010) Dig Dis , vol.28 , pp. 155-161
    • Bellentani, S.1    Scaglioni, F.2    Marino, M.3    Bedogni, G.4
  • 2
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • 1:CAS:528:DC%2BD38XivVOmsrY%3D 11961152
    • Angulo P. Nonalcoholic fatty liver disease. New Engl J Med. 2002;346:1221-31.
    • (2002) New Engl J Med , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 3
    • 84880419922 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches
    • 1:CAS:528:DC%2BC3sXhtFeqt77J 23855299
    • Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 2013;28:68-76.
    • (2013) J Gastroenterol Hepatol , vol.28 , pp. 68-76
    • Schuppan, D.1    Schattenberg, J.M.2
  • 4
    • 84880008350 scopus 로고    scopus 로고
    • The expanding role of fish models in understanding non-alcoholic fatty liver disease
    • 3701210 1:CAS:528:DC%2BC3sXht1Chsr3O 23720231
    • Asaoka Y, Terai S, Sakaida I, Nishina H. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis Model Mech. 2013;6:905-14.
    • (2013) Dis Model Mech , vol.6 , pp. 905-914
    • Asaoka, Y.1    Terai, S.2    Sakaida, I.3    Nishina, H.4
  • 5
    • 38749152419 scopus 로고    scopus 로고
    • Evolving trends in nonalcoholic fatty liver disease
    • 1:CAS:528:DC%2BD1cXhtlymsL4%3D 18249301
    • Delgado J-S. Evolving trends in nonalcoholic fatty liver disease. Eur J Intern Med. 2008;19:75-82.
    • (2008) Eur J Intern Med , vol.19 , pp. 75-82
    • Delgado, J.-S.1
  • 6
    • 34250342630 scopus 로고    scopus 로고
    • Good fat/bad fat
    • 1:CAS:528:DC%2BD2sXnvFalt7g%3D 17538963
    • McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. Hepatology. 2007;45:1343-6.
    • (2007) Hepatology , vol.45 , pp. 1343-1346
    • McClain, C.J.1    Barve, S.2    Deaciuc, I.3
  • 7
    • 34250356015 scopus 로고    scopus 로고
    • Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
    • 1:CAS:528:DC%2BD2sXnvFaltLw%3D 17476695
    • Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366-74.
    • (2007) Hepatology , vol.45 , pp. 1366-1374
    • Yamaguchi, K.1    Yang, L.2    McCall, S.3    Huang, J.4    Yu, X.X.5    Pandey, S.K.6
  • 8
    • 84857949744 scopus 로고    scopus 로고
    • Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: Role for oxidative-nitrosative stress
    • 3312982 1:CAS:528:DC%2BC38XktlKqsrY%3D 22366714
    • Lupachyk S, Watcho P, Hasanova N, Julius U, Obrosova IG. Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress. Free Radic Biol Med. 2012;52:1255-63.
    • (2012) Free Radic Biol Med , vol.52 , pp. 1255-1263
    • Lupachyk, S.1    Watcho, P.2    Hasanova, N.3    Julius, U.4    Obrosova, I.G.5
  • 9
    • 84878437339 scopus 로고    scopus 로고
    • Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects
    • 3690693 1:CAS:528:DC%2BC3sXhtVWmtrbI 23529132
    • Liang H, Tantiwong P, Sriwijitkamol A, Shanmugasundaram K, Mohan S, Espinoza S, et al. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects. J Physiol. 2013;591:2897-909.
    • (2013) J Physiol , vol.591 , pp. 2897-2909
    • Liang, H.1    Tantiwong, P.2    Sriwijitkamol, A.3    Shanmugasundaram, K.4    Mohan, S.5    Espinoza, S.6
  • 10
    • 84856400955 scopus 로고    scopus 로고
    • High free fatty acids level related with cardiac dysfunction in obese rats
    • 1:CAS:528:DC%2BC38XhsFGjtrg%3D 22088789
    • Sun X, Pan H, Tan H, Yu Y. High free fatty acids level related with cardiac dysfunction in obese rats. Diabetes Res Clin Pract. 2012;95:251-9.
    • (2012) Diabetes Res Clin Pract , vol.95 , pp. 251-259
    • Sun, X.1    Pan, H.2    Tan, H.3    Yu, Y.4
  • 12
    • 20044374023 scopus 로고    scopus 로고
    • Design and validation of a histological scoring system for nonalcoholic fatty liver disease
    • 15915461
    • Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
    • (2005) Hepatology , vol.41 , pp. 1313-1321
    • Kleiner, D.E.1    Brunt, E.M.2    Van Natta, M.3    Behling, C.4    Contos, M.J.5    Cummings, O.W.6
  • 13
    • 78651089694 scopus 로고    scopus 로고
    • Animal models of nonalcoholic fatty liver disease
    • 21119613
    • Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2011;8:35-44.
    • (2011) Nat Rev Gastroenterol Hepatol , vol.8 , pp. 35-44
    • Hebbard, L.1    George, J.2
  • 14
    • 33644955272 scopus 로고    scopus 로고
    • Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
    • 2517349 1:CAS:528:DC%2BD28XislOksbc%3D 16436109
    • Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1-16.
    • (2006) Int J Exp Pathol , vol.87 , pp. 1-16
    • Anstee, Q.M.1    Goldin, R.D.2
  • 15
    • 0037453056 scopus 로고    scopus 로고
    • Triglyceride accumulation protects against fatty acid-induced lipotoxicity
    • 152249 1:CAS:528:DC%2BD3sXisVCnsLs%3D 12629214
    • Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A. 2003;100:3077-82.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 3077-3082
    • Listenberger, L.L.1    Han, X.2    Lewis, S.E.3    Cases, S.4    Farese, R.V.5    Ory, D.S.6
  • 16
    • 77955690182 scopus 로고    scopus 로고
    • Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
    • 20683968
    • Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52:774-88.
    • (2010) Hepatology , vol.52 , pp. 774-788
    • Neuschwander-Tetri, B.A.1
  • 17
    • 0035896515 scopus 로고    scopus 로고
    • Natural ceramide reverses Fas resistance of acid sphingomyelinase-/- hepatocytes
    • 1:CAS:528:DC%2BD3MXitFKgtr4%3D 11096096
    • Paris F, Grassmé H, Cremesti A, Zager J, Fong Y, Haimovitz-Friedman A, et al. Natural ceramide reverses Fas resistance of acid sphingomyelinase-/- hepatocytes. J Biol Chem. 2001;276:8297-305.
    • (2001) J Biol Chem , vol.276 , pp. 8297-8305
    • Paris, F.1    Grassmé, H.2    Cremesti, A.3    Zager, J.4    Fong, Y.5    Haimovitz-Friedman, A.6
  • 18
    • 84892952980 scopus 로고    scopus 로고
    • Production of reactive oxygen species in the diabetic heart
    • 1:CAS:528:DC%2BC2cXltFKhtrc%3D 24334638
    • Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, et al. Production of reactive oxygen species in the diabetic heart. Circ J. 2014;78:300-6.
    • (2014) Circ J , vol.78 , pp. 300-306
    • Teshima, Y.1    Takahashi, N.2    Nishio, S.3    Saito, S.4    Kondo, H.5    Fukui, A.6
  • 19
    • 38049186666 scopus 로고    scopus 로고
    • Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
    • 1:CAS:528:DC%2BD1cXktVWqtQ%3D%3D 17951222
    • Han MS, Park SY, Shinzawa K, Kim S, Chung KW, Lee J-H, et al. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res. 2008;49:84-97.
    • (2008) J Lipid Res , vol.49 , pp. 84-97
    • Han, M.S.1    Park, S.Y.2    Shinzawa, K.3    Kim, S.4    Chung, K.W.5    Lee, J.-H.6
  • 20
    • 34347235098 scopus 로고    scopus 로고
    • Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
    • 1:CAS:528:DC%2BD2sXotlCitLg%3D 17618857
    • Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 2007;6:69-78.
    • (2007) Cell Metab , vol.6 , pp. 69-78
    • Monetti, M.1    Levin, M.C.2    Watt, M.J.3    Sajan, M.P.4    Marmor, S.5    Hubbard, B.K.6
  • 21
    • 84867861053 scopus 로고    scopus 로고
    • Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models
    • 1:CAS:528:DC%2BC38XhslSntrvO 23038002
    • Miyashita T, Toyoda Y, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. J Toxicol Sci. 2012;37:931-42.
    • (2012) J Toxicol Sci , vol.37 , pp. 931-942
    • Miyashita, T.1    Toyoda, Y.2    Tsuneyama, K.3    Fukami, T.4    Nakajima, M.5    Yokoi, T.6
  • 22
    • 49449099979 scopus 로고    scopus 로고
    • Osthole regulates enzyme protein expression of CYP7A1 and DGAT2 via activation of PPARα/γ in fat milk-induced fatty liver rats
    • 1:CAS:528:DC%2BD1cXpsFOjsLs%3D
    • Zhang Y, Xie M-L, Xue J, Gu Z-L. Osthole regulates enzyme protein expression of CYP7A1 and DGAT2 via activation of PPARα/γ in fat milk-induced fatty liver rats. J Asian Nat Prod Res. 2008;10:797-802.
    • (2008) J Asian Nat Prod Res , vol.10 , pp. 797-802
    • Zhang, Y.1    Xie, M.-L.2    Xue, J.3    Gu, Z.-L.4
  • 23
    • 84897382346 scopus 로고    scopus 로고
    • Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats
    • 3906058 24489777
    • Li S, Meng F, Liao X, Wang Y, Sun Z, Guo F, et al. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014;9, e86724.
    • (2014) PLoS One , vol.9
    • Li, S.1    Meng, F.2    Liao, X.3    Wang, Y.4    Sun, Z.5    Guo, F.6
  • 24
    • 84907598757 scopus 로고    scopus 로고
    • Long-term intake of soyabean phytosterols lowers serum TAG and NEFA concentrations, increases bile acid synthesis and protects against fatty liver development in dyslipidaemic hamsters
    • 1:CAS:528:DC%2BC2cXhtlyku77M 24932972
    • Laos S, Caimari A, Crescenti A, Lakkis J, Puiggròs F, Arola L, et al. Long-term intake of soyabean phytosterols lowers serum TAG and NEFA concentrations, increases bile acid synthesis and protects against fatty liver development in dyslipidaemic hamsters. Br J Nutr. 2014;112:663-73.
    • (2014) Br J Nutr , vol.112 , pp. 663-673
    • Laos, S.1    Caimari, A.2    Crescenti, A.3    Lakkis, J.4    Puiggròs, F.5    Arola, L.6
  • 25
    • 0035937174 scopus 로고    scopus 로고
    • Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia
    • 1:CAS:528:DC%2BD3MXhs1Kmsbg%3D 11096093
    • Lee Y, Wang M-Y, Kakuma T, Wang Z-W, Babcock E, McCorkle K, et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem. 2001;276:5629-35.
    • (2001) J Biol Chem , vol.276 , pp. 5629-5635
    • Lee, Y.1    Wang, M.-Y.2    Kakuma, T.3    Wang, Z.-W.4    Babcock, E.5    McCorkle, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.